Abstract | BACKGROUND: METHODS: Using immunohistochemical detection, the present study analyzed the clinical relevance of KRS expression in tumor cells and tumor-associated inflammatory cells (TAI) in 457 patients who underwent curative radical surgery and standard adjuvant therapy and who were observed on long-term follow-up. RESULTS: High expression of KRS in tumor cells ( tumor-KRS(+)) was noted in 43.3 % (198 of 457) of cases. High expression of KRS in tumor-associated inflammatory cells (TAI-KRS(+)) including macrophages/monocytes, CD4-positive T cells, and/or neutrophils was observed in 37.2 % (170 of 457) of cases. Status of KRS in the tumor and TAI revealed an association with the known clinicopathological parameters for prognosis of gastric cancer. Tumor-KRS(+) status correlated to shorter overall survival, especially in stage III to IV cancers (P = 0.003), while TAI-KRS(+) status correlated significantly to longer overall survival in gastric cancer (P = 0.049). Cases with tumor-KRS(+) and TAI-KRS(-) status showed significantly reduced survival rates compared to those of other cases (P = 0.010), and status of tumor-KRS(+) and TAI-KRS(-) was revealed as an independently poor prognostic factor of overall survival (P = 0.001). CONCLUSIONS: KRS-related inflammation can be identified in a subset of gastric cancer. This may be a possible mechanism of immune surveillance against tumor progression. In addition, expression status of KRS in tumor and TAI may be an independent prognostic marker for gastric cancer patients.
|
Authors | Baek-Hui Kim, Woon Yong Jung, Hyunjoo Lee, Youngran Kang, You-Jin Jang, Soon Won Hong, Hyeong-Jae Jeong, Sun Och Yoon |
Journal | Annals of surgical oncology
(Ann Surg Oncol)
Vol. 21
Issue 6
Pg. 2020-7
(Jun 2014)
ISSN: 1534-4681 [Electronic] United States |
PMID | 24558064
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ki-67 Antigen
- Tumor Necrosis Factor-alpha
- Lysine-tRNA Ligase
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- CD4-Positive T-Lymphocytes
(chemistry)
- Carcinoma
(chemistry, pathology, therapy)
- Female
- Humans
- Inflammation
(pathology)
- Ki-67 Antigen
(analysis)
- Lysine-tRNA Ligase
(analysis)
- Macrophages
(chemistry)
- Male
- Middle Aged
- Monocytes
(chemistry)
- Neoplasm Invasiveness
- Neoplasm Staging
- Neutrophils
(chemistry)
- Stomach Neoplasms
(chemistry, pathology, therapy)
- Survival Rate
- Tumor Necrosis Factor-alpha
(analysis)
|